Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Labrie, C.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Availability
Open access
(7)
+
-
Creation Date
2020
(2)
+
-
2023
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Scholarly Publications
(3)
+
-
Topic
immunotherapy
(3)
+
-
active
(2)
+
-
tumor microenvironment
(2)
+
-
Author
Burg, S.H. van der
(7)
+
-
Hall, T. van
(7)
+
-
Labrie, C.
(7)
+
-
Arens, R.
(3)
+
-
Elsas, M.J. van
(3)
+
-
Griffioen, L.
(3)
+
-
Groeneveldt, C.
(3)
+
-
Hoeben, R.C.
(3)
+
-
Kinderman, P.
(3)
+
-
Montfoort, N. van
(3)
+
-
Nejad, E.B.
(3)
+
-
Wollenberg, D.J.M. van den
(3)
+
-
Duikeren, S. van
(2)
+
-
Franken, K.L.M.C.
(2)
+
-
Kleinovink, J.W.
(2)
+
-
Sluijter, M.
(2)
+
-
Sluis, T.C. van der
(2)
+
-
Thans, J.J.C.V.
(2)
+
-
Show more
Language
en
(7)
+
-
Search results
(1 - 7 of 7)
show grid
show list
save search
Neutralizing antibodies impair the oncolytic efficacy of reovirus but permit effective combination with T cell-based immunotherapies
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy
Intertumoral differences dictate the outcome of TGF-β blockade on the efficacy of viro-immunotherapy
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy